Differentiated Thyroid Cancer with Thyroglobulin Elevation and Negative Iodine Scintigraphy (TENIS Syndrome)

作者: Raja Sfar , Tarek Kamoun , Manel Nouira , Hamza Regaieg , Nouha Ammar

DOI: 10.4236/IJOHNS.2014.34028

关键词:

摘要: Background and Objectives: Following the initial management, some patients with differentiated thyroid cancer (DTC) develop a state of high thyroglobulin (Tg) Negative Iodine Scintigraphy. The predisposing factors outcome this condition are unclear. In this study, our objectives were to analyze the characteristics Tg level negative Iodine scintigraphy determine predictive for development of high negative scintigraphy. Patients Methods: Retrospective study of 34 undergoing treatment DTC, followed in Nuclear Medicine department University Hospital—Sahloul Sousse between 1990 2006 having Fourteen had between 2 10 ng/ml, 16 had 11 100 ng/ml 4 more than ng/ml. Results: There were 25 women 9 men. mean age was 51.65 years. 94.1% cases, tumor was papillary carcinoma. Follicular tumors accounted only 5.9%. mean nodule size was3.26 cm. Capsular invasion seen 47.1% cases. locoregional found in 35.3%. lymph node extension found 84.8% lymph node surgery. Lymph involvement observed 92.8% with papillary cancer but it 7.2% follicular cancers. Lymph unilateral 28.6% (N1a) bilateral, contralateral or mediastinal 71.4% (N1b). Initial as follows: 7 patients had 14 12 ng/ml. The number radioactive Iodine cure 11.08 more than significant difference (P = 0.001). Conclusion: Among epidemiological, pathological clinical characteristics, is most frequent parameter found DTC

参考文章(12)
M Klain, M Pulcrano, B Biondi, M Salvatore, L Pagano, F Pasano, G Angellotti, G Lombardi, Follow-up of differentiated thyroid carcinoma. Minerva Endocrinologica. ,vol. 29, pp. 161- 174 ,(2004)
Alberto Vignati, Massimo E. Dottorini, Luigia Colombo, Liliana Mazzucchelli, Giuseppe Lomuscio, Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients. The Journal of Nuclear Medicine. ,vol. 38, pp. 669- 675 ,(1997)
E. L. Mazzaferri, R. J. Robbins, C. A. Spencer, L. E. Braverman, F. Pacini, L. Wartofsky, B. R. Haugen, S. I. Sherman, D. S. Cooper, G. D. Braunstein, S. Lee, T. F. Davies, B. M. Arafah, P. W. Ladenson, A. Pinchera, A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. The Journal of Clinical Endocrinology and Metabolism. ,vol. 88, pp. 1433- 1441 ,(2003) , 10.1210/JC.2002-021702
Pedro Weslley S. Rosário, Flávia Coimbra P. Maia, Álvaro Luís Barroso, Saulo Purisch, Abordagem dos pacientes com carcinoma diferenciado de tireóide com tireoglobulina sérica elevada e pesquisa de corpo inteiro negativa Arquivos Brasileiros De Endocrinologia E Metabologia. ,vol. 49, pp. 246- 252 ,(2005) , 10.1590/S0004-27302005000200011
M. Luster, S. E. Clarke, M. Dietlein, M. Lassmann, P. Lind, W. J. G. Oyen, J. Tennvall, E. Bombardieri, Guidelines for radioiodine therapy of differentiated thyroid cancer European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 35, pp. 1941- 1959 ,(2008) , 10.1007/S00259-008-0883-1
John C. Morris, Stefan K. G. Grebe, Carol M. Preissner, Dennis J. O’Kane, Ravinder J. Singh, Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays. The Journal of Clinical Endocrinology and Metabolism. ,vol. 88, pp. 3069- 3074 ,(2003) , 10.1210/JC.2003-030122
F. Pacini, L. Agate, R. Elisei, M. Capezzone, C. Ceccarelli, F. Lippi, E. Molinaro, A. Pinchera, Outcome of Differentiated Thyroid Cancer with Detectable Serum Tg and Negative Diagnostic 131I Whole Body Scan: Comparison of Patients Treated with High 131I Activities Versus Untreated Patients The Journal of Clinical Endocrinology and Metabolism. ,vol. 86, pp. 4092- 4097 ,(2001) , 10.1210/JCEM.86.9.7831
Ernest L. Mazzaferri, Empirically treating high serum thyroglobulin levels. The Journal of Nuclear Medicine. ,vol. 46, pp. 1079- 1088 ,(2005)